BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23864951)

  • 1. Chronic NaHS Treatment Is Vasoprotective in High-Fat-Fed ApoE(-/-) Mice.
    Ford A; Al-Magableh M; Gaspari TA; Hart JL
    Int J Vasc Med; 2013; 2013():915983. PubMed ID: 23864951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSE/H
    Lu X; Wang S; Feng S; Li H
    BMC Nephrol; 2020 Dec; 21(1):527. PubMed ID: 33276745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.
    Al-Magableh MR; Kemp-Harper BK; Hart JL
    Hypertens Res; 2015 Jan; 38(1):13-20. PubMed ID: 25099489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis.
    Mani S; Li H; Untereiner A; Wu L; Yang G; Austin RC; Dickhout JG; Lhoták Š; Meng QH; Wang R
    Circulation; 2013 Jun; 127(25):2523-34. PubMed ID: 23704252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.
    Sekiguchi F; Miyamoto Y; Kanaoka D; Ide H; Yoshida S; Ohkubo T; Kawabata A
    Biochem Biophys Res Commun; 2014 Feb; 445(1):225-9. PubMed ID: 24508802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
    Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
    Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation.
    Lin Y; Chen Y; Zhu N; Zhao S; Fan J; Liu E
    Biomed Pharmacother; 2016 Oct; 83():466-476. PubMed ID: 27427853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of estrogen and CSE/H
    Li H; Mani S; Wu L; Fu M; Shuang T; Xu C; Wang R
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H406-H414. PubMed ID: 27986657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen Sulfide Protects Against Uremic Accelerated Atherosclerosis via nPKCδ/Akt Signal Pathway.
    Lu X; Li H; Wang S
    Front Mol Biosci; 2020; 7():615816. PubMed ID: 33644113
    [No Abstract]   [Full Text] [Related]  

  • 10. Endogenous hydrogen sulfide improves vascular remodeling through PPARδ/SOCS3 signaling.
    Tian D; Teng X; Jin S; Chen Y; Xue H; Xiao L; Wu Y
    J Adv Res; 2021 Jan; 27():115-125. PubMed ID: 33318871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous hydrogen sulfide-mediated MAPK inhibition preserves endothelial function through TXNIP signaling.
    Tian D; Dong J; Jin S; Teng X; Wu Y
    Free Radic Biol Med; 2017 Sep; 110():291-299. PubMed ID: 28669627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased vascular H2S production is associated with vascular oxidative stress in rats fed a high-fat western diet.
    Jenkins TA; Nguyen JC; Hart JL
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):783-90. PubMed ID: 27087304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
    Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
    Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
    Xu S; Liu Z; Liu P
    Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
    Cheung SH; Kwok WK; To KF; Lau JY
    PLoS One; 2014; 9(11):e113038. PubMed ID: 25397776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between hydrogen sulfide and nitric oxide on cardiac protection in rats with metabolic syndrome.
    Rong-na L; Xiang-jun Z; Yu-han C; Ling-qiao L; Gang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):25-32. PubMed ID: 21375934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of type 1 diabetes on the production and vasoactivity of hydrogen sulfide in rat middle cerebral arteries.
    Streeter EY; Badoer E; Woodman OL; Hart JL
    Physiol Rep; 2013 Oct; 1(5):e00111. PubMed ID: 24303182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia potentiates diabetes-impaired EDHF-induced vascular relaxation: Role of insufficient hydrogen sulfide.
    Cheng Z; Shen X; Jiang X; Shan H; Cimini M; Fang P; Ji Y; Park JY; Drosatos K; Yang X; Kevil CG; Kishore R; Wang H
    Redox Biol; 2018 Jun; 16():215-225. PubMed ID: 29524844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats.
    Velasco-Xolalpa ME; Barragán-Iglesias P; Roa-Coria JE; Godínez-Chaparro B; Flores-Murrieta FJ; Torres-López JE; Araiza-Saldaña CI; Navarrete A; Rocha-González HI
    Neuroscience; 2013 Oct; 250():786-97. PubMed ID: 23830907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H
    Wu W; Hou CL; Mu XP; Sun C; Zhu YC; Wang MJ; Lv QZ
    Oxid Med Cell Longev; 2017; 2017():5707830. PubMed ID: 28512525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.